Farhad Hafezi, ESCRS 2021: Development of an Effective Epithelium-on Procedure
It was great to speak with Farhad Hafezi (ELZA Institute, Zurich, Switzerland) about the recent advances that have made an epithelium-on corneal cross-linking procedure possible.
- Why has it taken so long to develop an effective epithelium-on procedure (00:13)
Speaker Disclosure: Farhad Hafezi holds patents and applications for corneal apparatus used for CXL, chromophore for CXL application; and is a shareholder and investor for EMAGine AG.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of ESCRS 2021.
Share this Video
Related Videos In Corneal and External Disorders
John D Sheppard, Hawaiian Eye and Retina 2023: Phaco and keratopathy – sequential or combined keratoplasty?
It was a pleasure to have the opportunity to meet with Dr John D Sheppard (Eastern Virginia Medical School, Norfolk, VA, USA) about his presentation on what to consider when choosing between sequential or combined keratoplasty. Questions: What are the advantages and disadvantages of combined phacoemulsification and keratoplasty versus sequential surgery? (0:10) What patient factors […]
John D Sheppard, Hawaiian Eye and Retina 2023: Highlights
We were delighted to speak with Dr John D Sheppard (Eastern Virginia Medical School, Norfolk, VA, USA) about his highlights from Hawaiian Eye and Retina 2023, and his views on the role of penetrating keratoplasty in the era of selective lamellar keratoplasty. Questions: What have you gained most from attending the Hawaiian Eye meeting? (0:09) […]
Kenneth A Beckman, Hawaiian Eye and Retina 2023: Highlights and developments in intraocular lenses
We were delighted to speak with Dr Kenneth A Beckman (Comprehensive Eyecare of Central Ohio, Westerville, OH, USA) on his highlights from Hawaiian Eye and Retina 2023, and his views on the future of intraocular lens technology. Questions: What have been your highlights of Hawaiian Eye and Retina 2023? (0:20) What have been the most […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!